Pillstats
Rx only · Solution · Topical

Testosterone

Testosterone

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers7 labelers
Packages8
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.192$0.384$0.576$0.768Dec 2025Mar 2026Jun 2026
$0.602
Latest avg · Jun 17, 2026
-9%
Since Dec 17, 2025
7
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager2SUPPLYING
Actavis Pharma, Inc.unknown1SUPPLYING
Alembic Pharmaceuticals Limitedunknown1SUPPLYING
Encube Ethicals, Inc.unknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
Padagis Israel Pharmaceuticals Ltdunknown1SUPPLYING
Cipla USA Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.